---
title: "Psych News Alert: Johnson & Johnson to Pay More Than $2 Billion in Risperdal Marketing Case"
description: Pharmaceutical firm Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liabi...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/shutterstock_1523473-Jun-24-2025-09-41-52-5104-PM.jpg
---

 11/5/13 12:00 AM

# Johnson & Johnson to Pay More Than $2 Billion in Risperdal Marketing Case

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html)

| [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/shutterstock_1523473-4.jpg?width=200&name=shutterstock_1523473-4.jpg)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/shutterstock_1523473-4.jpg) |  |
| --- | --- |

Pharmaceutical firm Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability charges arising from allegations relating to the antipsychotic drugs Risperdal and Invega and the cardiac drug Natrecor. The charges include promotion of the products for uses not approved by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the nation’s largest long-term-care pharmacy provider.

The resolution is one of the largest health care fraud settlements in U.S. history, with criminal fines and forfeitures totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion, according to a [statement](http://www.justice.gov/opa/pr/2013/November/13-ag-1170.html) released by the U.S. Justice Department.

The government charged that from March 2002 through December 2003, Janssen Pharmaceuticals Inc., a subsidiary of J&J, introduced Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. For most of this time period, Risperdal was approved only to treat schizophrenia. The government said that Janssen’s sales representatives promoted Risperdal to physicians and other prescribers who treat elderly dementia patients by urging the prescribers to use it to treat symptoms such as anxiety, agitation, depression, hostility, and confusion. The government also said that the company created written sales aids for use by Janssen’s ElderCare sales force that emphasized symptoms and minimized mention of the FDA-approved use, treatment of schizophrenia.

The settlement involves similar charges related to the marketing of Invega and the heart-failure drug Natrecor.

"This multibillion-dollar resolution demonstrates the Justice Department’s firm commitment to preventing and combating all forms of health care fraud," said Attorney General Eric Holder in a statement. "And it proves our determination to hold accountable any corporation that breaks the law and enriches its bottom line at the expense of the American people.”

For information on related lawsuits, see the Med Check item in *Psychiatric News* titled "[Jury Finds Johnson and Johnson Guilty in Risperdal Case](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1157612)." 

(Image: James Steidl/shutterstock.com)

[Risperdal](https://alert.psychnews.org/tag/risperdal), [Johnson and Johnson](https://alert.psychnews.org/tag/johnson-and-johnson), [marketing](https://alert.psychnews.org/tag/marketing)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/gavel_59373811-Jun-24-2025-10-25-39-8605-PM.jpg?height=200&name=gavel_59373811-Jun-24-2025-10-25-39-8605-PM.jpg) ](https://alert.psychnews.org/2012/04/arkansas-jury-finds-johnson-johnson.html)

[Risperdal](https://alert.psychnews.org/tag/risperdal), [risperidone](https://alert.psychnews.org/tag/risperidone), [Johnson and Johnson](https://alert.psychnews.org/tag/johnson-and-johnson)

## [Arkansas Jury Finds Johnson & Johnson Guilty in Latest Risperdal Case](https://alert.psychnews.org/2012/04/arkansas-jury-finds-johnson-johnson.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 4/12/12 12:00 AM

Johnson & Johnson (J&J) "lied to patients and doctors" in its claims about its antipsychotic...

[ Read more ](https://alert.psychnews.org/2012/04/arkansas-jury-finds-johnson-johnson.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/murphy_f%5B1%5D-Jun-24-2025-05-27-48-4089-PM.gif?height=200&name=murphy_f%5B1%5D-Jun-24-2025-05-27-48-4089-PM.gif) ](https://alert.psychnews.org/2015/06/reps-murphy-johnson-reintroduce-house.html)

[Rep. Tim Murphy](https://alert.psychnews.org/tag/rep-tim-murphy), [mental health reform](https://alert.psychnews.org/tag/mental-health-reform), [Rep. Eddie Bernice Johnson](https://alert.psychnews.org/tag/rep-eddie-bernice-johnson), [Helping Families in Mental Heath Crisis Act](https://alert.psychnews.org/tag/helping-families-in-mental-heath-crisis-act), [reintroduce](https://alert.psychnews.org/tag/reintroduce)

## [Reps. Murphy, Johnson Reintroduce House Mental Health Reform Bill](https://alert.psychnews.org/2015/06/reps-murphy-johnson-reintroduce-house.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 6/5/15 12:00 AM

Rep. Tim Murphy (R-Pa.) and Rep. Eddie Bernice Johnson (D-Texas) reintroduced the Helping Families...

[ Read more ](https://alert.psychnews.org/2015/06/reps-murphy-johnson-reintroduce-house.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/shutterstock_109500080-Jun-24-2025-04-22-44-4990-PM.jpg?height=200&name=shutterstock_109500080-Jun-24-2025-04-22-44-4990-PM.jpg) ](https://alert.psychnews.org/2012/08/181-million-settlement-announced-in.html)

[Risperdal](https://alert.psychnews.org/tag/risperdal), [lawsuit](https://alert.psychnews.org/tag/lawsuit), [Janssen Pharmaceuticals](https://alert.psychnews.org/tag/janssen-pharmaceuticals)

## [$181 Million Settlement Announced in Risperdal Marketing Suit](https://alert.psychnews.org/2012/08/181-million-settlement-announced-in.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 8/31/12 12:00 AM

Janssen Pharmaceuticals, a division of Johnson & Johnson, announced yesterday that it reached a...

[ Read more ](https://alert.psychnews.org/2012/08/181-million-settlement-announced-in.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T21:43:58.787Z",
  "datePublished" : "2013-11-05T05:00:00.000Z",
  "headline" : "Psych News Alert: Johnson & Johnson to Pay More Than $2 Billion in Risperdal Marketing Case",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/shutterstock_1523473-Jun-24-2025-09-41-52-5104-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2013/11/johnson-johnson-to-pay-more-than-2.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```